Clinical Trials on Contamination by COVID 19 During Oral Care in Hong Kong
Total 27 results
-
Hong Kong Baptist UniversityRecruitingLong Covid19 | Neuropsychiatric Symptoms | Electro-acupunctureHong Kong
-
Chinese University of Hong KongActive, not recruiting
-
The University of Hong KongRecruiting
-
Hong Kong Baptist UniversityJiangzhong Pharmaceutical Co., Ltd.Recruiting
-
The University of Hong KongRecruitingPredicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine LearningOral Squamous Cell CarcinomaHong Kong
-
The University of Hong KongRecruiting
-
Chinese University of Hong KongCompletedUrologic Neoplasms | Urologic Diseases | Nasopharyngeal Neoplasms | Colorectal Neoplasms | Oropharyngeal Neoplasms | Hypopharyngeal Neoplasms | Laryngeal Neoplasms | Oral Neoplasms | ENT DiseasesChina
-
The University of Hong KongRecruitingCardiovascular Diseases | Hypertension | Diabetes Mellitus | Cancer | Kidney Disease, Chronic | Noncommunicable Diseases | Chronic Respiratory DiseaseChina
-
Chinese University of Hong KongCompletedCovid19 | IgG4 Related DiseaseHong Kong
-
Chinese University of Hong KongCompletedCOVID-19 | Chronic Kidney Disease stage4 | Chronc Kidney Disease Stage 5Hong Kong
-
Żelazna Medical Centre, LLCCharles University, Czech Republic; Karolinska Institutet; Charite University... and other collaboratorsUnknownDepression | Anxiety | Pregnancy RelatedLebanon, Hong Kong, United States, Sweden, Germany, Australia, Poland, Italy, Taiwan, Albania, Czechia, France, Israel, Norway, Spain
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditionsUnited States, China
-
Regeneron PharmaceuticalsTerminated
-
Merck Sharp & Dohme LLCCompletedPapillomavirus Infections | Coronavirus Disease (COVID-19)United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation Toxicity | Oral Complications of Radiation TherapyUnited States
-
Regeneron PharmaceuticalsCompleted
-
QuantumLeap Healthcare CollaborativeM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pennsylvania and other collaboratorsRecruitingCOVID-19United States
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
PfizerCompletedCOVID-19United States, Taiwan, Italy, Canada, Greece
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Oral ComplicationsUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | Stage... and other conditionsUnited States, Canada, China
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation Toxicity | Oral ComplicationsUnited States, Canada
-
Daiichi Sankyo, Inc.CompletedHead and Neck Cancer | Radiation Toxicity | Oral ComplicationsUnited States